TAM
ARIA

Tocqueville Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Tocqueville Asset Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-57,500
Closed -$463K – 1857
2014
Q1 		$463K Buy
57,500
+42,500
+283% +$331K 0.01% 594
2013
Q4 		$102K Sell
15,000
-19,300
-56% -$104K ﹤0.01% 930
2013
Q3 		$631K Buy
34,300
+2,000
+6% +$38.8K 0.01% 588
2013
Q2 		$565K Buy
+32,300
New +$573K 0.01% 606

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tocqueville Asset Management's ARIA Position: Q2 2014 in Review

Tocqueville Asset Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2014, closing a stake of 57,500 shares — an estimated $463K sold.

Tocqueville Asset Management first reported a position in ARIA in Q2 2013 and held it in 4 quarters. The position peaked at $631K in Q3 2013. 169 funds tracked by Wall St. Rank hold ARIA as of Q2 2014.

  • Tocqueville Asset Management reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • Tocqueville Asset Management sold 57,500 Ariad Pharmaceuticals Inc shares in Q2 2014, an estimated $463K.
  • Tocqueville Asset Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
  • Tocqueville Asset Management's Ariad Pharmaceuticals Inc position peaked at $631K in Q3 2013.
  • 169 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2014.

Based on Tocqueville Asset Management's 13F filing for Q2 2014, filed 30 Jul 2014.